Join to view full profile
43 New Scotland Ave# MailAlbany, NY 12208
Phone+1 518-262-6696
Dr. Shaffer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1995 - 1998
University of North Carolina at Chapel Hill School of MedicineClass of 1995
Certifications & Licensure
NY State Medical License 1998 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification iKnowMed™ EHR, US Oncology, 2012, 2014-2017
Clinical Trials
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- Author Correction: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.Guocan Wang, Andrea Lunardi, Jiangwen Zhang, Zhenbang Chen, Ugo Ala
Nature Genetics. 2026-03-01 - 11 citationsA Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.Pavlos Msaouel, Randy F Sweis, Manojkumar Bupathi, Elisabeth Heath, Oscar B Goodman Jr
European Urology Oncology. 2024-08-01 - 44 citationsNivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.Karim Fizazi, Margitta Retz, Daniel P Petrylak, Jeffrey C Goh, Jose Perez-Gracia
Journal for Immunotherapy of Cancer. 2022-08-01
Press Mentions
Medical Monday: Oncology with Dr. David ShafferNovember 9th, 2016
Grant Support
- Research Training In Child PsychiatryNational Institute Of Mental Health1994–2009
- Core--Research MethodsNational Institute Of Mental Health2004–2008
- Acisr For Pediatric Psychiatry DisordersNational Institute Of Mental Health2004–2008
- Child Psychiatry Intervention Research CenterNational Institute Of Mental Health1999–2003
- Sucidial Youth Four Years After Preventive ScreeningNational Institute Of Mental Health1997–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
